Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1025687-58-4
Formula :	C₂₃H₂₄FN₆Na₂O₉P
M.W :	624.42
SMILES Code :	O=C1N(COP([O-])([O-])=O)C2=NC(NC3=NC(NC4=CC(OC)=C(OC)C(OC)=C4)=NC=C3F)=CC=C2OC1(C)C.[Na+].[Na+]
Synonyms :	R935788; NSC 745942; Fostamatinib
MDL No. :	MFCD15146370
InChI Key :	HSYBQXDGYCYSGA-UHFFFAOYSA-L
Pubchem ID :	25008120

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Neutrophils	1 μM	1 hour	To evaluate the effect of R406 on LPS-induced degranulation and cytokine release in neutrophils, results showed that R406 significantly reduced degranulation but had minimal impact on cytokine release	PMC11387147
Mouse platelets	1 µM	10 minutes	To validate the inhibitory effect of Fostamatinib on platelet signaling, results showed that R406 significantly reduced the activation of Syk and Src family kinases.	PMC10768010
Healthy donor washed human platelets	10 µM	10 minutes	R406 completely abolished the tyrosine phosphorylation of Syk, LAT, and PLCγ2 induced by atherosclerotic plaque homogenate and blocked upstream Src Y418 autophosphorylation at 10 μM concentration.	PMC9266367
Healthy donor washed human platelets	3 µM	10 minutes	R406 at 3 μM concentration significantly inhibited platelet aggregation in response to 70 μg/mL of plaque homogenate and completely blocked platelet aggregation in washed platelets at 10 μM concentration.	PMC9266367
Neutrophils	0.25, 0.5, 1 μM	2 h	Reduced LPS-induced neutrophil activation and ROS release	PMC11606345
BMDMs	500 nM	24 hours	To study the effect of Syk inhibitor R788 on BMDMs, results showed that R788 downregulated the expression of immunosuppressive genes.	PMC10416758
Healthy donor washed human platelets	10 µM	30 minutes	R406 at 10 μM concentration reduced platelet adhesion on atherosclerotic plaque under static conditions but did not affect the platelet surface area.	PMC9266367
THP-1 cells	10-20 μM	4 hours	To evaluate the inhibitory effect of Fostamatinib on TBK1 phosphorylation. The results showed that Fostamatinib significantly inhibited the phosphorylation levels of TBK1 and IRF3.	PMC10916235
Peritoneal macrophages	1 μM	6 h	Inhibited LPS-induced mRNA transcription of TNF-α, IL-6, CCL2, CCL3, and CXCL10	PMC11606345
Neutrophils	1 μM	8 hours	To evaluate the effect of R406 on LPS-induced NETosis in neutrophils, results showed that R406 effectively inhibited NETosis	PMC11387147
NSC-34 cells	10 μM		To evaluate the inhibitory effect of Fostamatinib on the cGAS/STING signaling pathway induced by ALS-related toxic proteins. The results showed that Fostamatinib significantly inhibited the phosphorylation of TBK1 and IRF3.	PMC10916235

Rats	Conscious and anaesthetized rats	Oral	10, 30, 100 mg/kg	Single dose, up to 24 hours	Fostamatinib dose-dependently increased blood pressure, and the time course of the BP effect correlated closely with the plasma concentrations of R406	PMC3997272
Mice	Ferric chloride-induced carotid artery thrombosis model	Oral	80 mg/kg	Single dose	Fostamatinib did not significantly affect arterial thrombus formation in mice.	PMC9266367
C57BL/6 mice	LPS-induced SIRS model	Oral	7.5, 15, 30 mg/kg	Once daily for 3 days	Reduced LPS-induced inflammatory factor levels and inhibited excessive consumption of neutrophils in bone marrow	PMC11606345
C57/B6 mice	Pancreatic cancer model	Intraperitoneal injection	50 mg/kg	Five times per week, until tumor harvest	To study the effect of R788 alone or in combination with Gem on pancreatic cancer tumor growth and metastasis, results showed that R788 significantly reduced tumor size and metastatic nodules.	PMC10416758

{[proInfo.proName]}

CAS No.: 1025687-58-4

{[proInfo.proName]}

CAS No.: 1025687-58-4

Product Citations

Alternative Products

Product Details of Fostamatinib Disodium

Safety of Fostamatinib Disodium

Related Pathways of Fostamatinib Disodium

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00798096	T Cell Lymphoma	PHASE2	COMPLETED	2025-04-10	Research Site, San Francisco, ... More >>California, 94143, United States\|Research Site, Stanford, California, 94305, United States\|Research Site, Atlanta, Georgia, 30322, United States\|Research Site, Boston, Massachusetts, 02115, United States\|Research Site, Rochester, Minnesota, 55905, United States\|Research Site, Omaha, Nebraska, 68198, United States\|Research Site, New York, New York, 10021, United States\|Research Site, Houston, Texas, 77030, United States\|Research Site, Vancouver, British Columbia, V5Z 4E6, Canada\|Research Site, Toronto, Ontario, M5G 2M9, Canada Less <<
NCT02077192	Immune Thrombocytopenic Purpur... More >>a Less <<	PHASE3	COMPLETED	2020-06-02	Arizona Oncology Associates, T... More >>ucson, Arizona, 85710, United States\|Bleeding & Clotting Disorders Institute, Peoria, Illinois, 61615, United States\|Horizon Oncology Research, Inc, Lafayette, Indiana, 47905, United States\|Center for Cancer and Blood Disorders, Bethesda, Maryland, 20817, United States\|Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, 10065, United States\|Weill Cornell Medicine, New York, New York, 10065, United States\|East Carolina University, Brody School of Medicine, Greenville, North Carolina, 27834, United States\|W.G. "Bill" Hefner VA Medical Center, Salisbury, North Carolina, 28144, United States\|Signal Point Clinical Research Center LLC, Middletown, Ohio, 45042, United States\|Concord Repatriation General Hospital, Concord, New South Wales, 2139, Australia\|Liverpool Hospital, Liverpool, New South Wales, 2170, Australia\|Prince of Wales Hospital, Randwick, New South Wales, 2031, Australia\|Westmead Hospital, Westmead, New South Wales, 2145, Australia\|Launceston General Hospital, Launceston, Tasmania, 7250, Australia\|The Alfred, Melbourne, Victoria, 3004, Australia\|Perth Blood Institute, Nedlands, Western Australia, 6009, Australia\|Hanusch-Krankenhaus Wiener Gebietskrankenkasse, Vienna, 1140, Austria\|Specialized Hospital for Active Treatment of Hematology Diseases, EAD, Sofia, Department of Chemotherapy, Hemotherapy and Blood Inherited Diseases to Clinic of Clinical Hematology;, Sofia, BG, 1756, Bulgaria\|UMHAT Dr. Georgi Stranski, EAD, Pleven, Clinic of Hematology, Pleven, 5800, Bulgaria\|UMHAT Aleksandrovska, EAD, Sofia, 1431, Bulgaria\|MHAT Hristo Botev, AD, Vratsa, First Internal Department, Vratsa, 3000, Bulgaria\|Hamilton Health Sciences Corporation, Hamilton, Ontario, L8N 3Z5, Canada\|St. Michael's Hospital, Toronto, Ontario, M5B1W8, Canada\|Fakultni nemocnice Brno, Brno, 625 00, Czechia\|Fakultni nemocnice Ostrava, Ostrava-Poruba, 708 52, Czechia\|Herlev Hospital, Herlev, DK, 2730, Denmark\|Pecsi Tudomanyegyetem Klinikai Kozpont, I. sz. Belgyogyaszati Klinika, Pecs, H-7624, Hungary\|Istituto di Ematologia "Lorenzo e Ariosto Seràgnoli", Bologna, BO, 40138, Italy\|Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" - Clinica Ematologica, Udine, 33100, Italy\|HAGA ziekenhuis, Den Haag, NL, 2545 CH, Netherlands\|Haukeland universitetssykehus, Helse Bergen HF, Bergen, 5021, Norway\|Sykehuset ?stfold Kalnes, Gr?lum, 1714, Norway\|Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wrocrlaw, Wroclaw, Dolnoslaski, 50-367, Poland\|Wojewodzki Szpital Specjalistyczny im. J. Korczaka, Slupsk, PO, 76-200, Poland\|Lkinika Hematologii I Transplantologii Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland\|SPZOZ Szpital Uniwersytecki w Krakowie Pracownia Separacji Krwinek i Bank Komórek Krwiotwórczych Klinika Hematologii, Kraków, 31-501, Poland\|Wojewódzki Szpital Specjalistyczny im. M. Kopernika w ?odzi, Lodz, 93-510, Poland\|Specjalistyczny Gabinet Lekarski, Lublin, 20-601, Poland\|Szpital Wojewodzki w Opolu, Opole, 45-061, Poland\|Instytut Hematologii I Transfuzjologii, Warszawa, 02-776, Poland\|Spitalul Clinic Colentina, Hematologie, Bucuresti, 020125, Romania\|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain\|Hospital Universitario La Paz, Madrid, 28046, Spain\|Hospital Universitari i Politécnic La Fe de Valencia, Valencia, 46026, Spain\|Colchester General Hospital, Colchester, Essex, CO4 5JL, United Kingdom\|Royal Victoria Infirmary, Newcastle-upon-Tyne, UK, NE1 4LP, United Kingdom\|Kent & Canterbury Hospital, Canterbury, CT1 3NG, United Kingdom\|James Paget University Hospital, Great Yarmouth, NR31 6LA, United Kingdom\|St. James's Hospital, Leeds, LS9 7TF, United Kingdom\|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom\|Royal Liverpool University Hospital, Liverpool, L78XP, United Kingdom\|Imperial College Healthcare NHS Trust, London, W12 0HS, United Kingdom\|University College Hospital, London, WC1E 6AG, United Kingdom\|Cancer and Haematology Centre, Oxford, OX3 7LE, United Kingdom\|University Hospital of North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, ST4 6QG, United Kingdom Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	1.60mL 0.32mL 0.16mL	8.01mL 1.60mL 0.80mL	16.01mL 3.20mL 1.60mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed